cyclosporine and Obesity

cyclosporine has been researched along with Obesity in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (26.92)	18.2507
2000's	15 (28.85)	29.6817
2010's	18 (34.62)	24.3611
2020's	5 (9.62)	2.80

Authors

Authors	Studies
Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H	1
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ	1
Calogero, A; Campanile, S; Carlomagno, N; Dodaro, C; Incollingo, P; Menkulazi, M; Peluso, G; Santangelo, ML; Scotti, A; Tammaro, V	1
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K	1
Jia, LQ; Jiang, XL; Kong, L; Kuang, JS; Lan, ZM; Li, Y; Lv, MJ; Song, N; Tai, H; Wu, J; Xiao, XS; Yang, GL; Yang, P; Yao, SC	1
Acebes, A; Brito-Casillas, Y; Cuesto, G; De Vries, APJ; Porrini, E; Rodriguez-Rodriguez, AE; Salido, E; Torres, A; Triñanes, J; Wagner, A	1
Baek, KH; Chau, GC; Seo, DS; Um, SH	1
Ahn, KJ; Choe, YB; Hong, JR; Lee, YW	1
Albhaisi, S; Arshad, T; Bhati, C; Driscoll, C; Lee, E; Patel, S; Reichman, T; Siddiqui, MB; Siddiqui, MS; Wolver, S	1
Adamowicz, A; Brzezińska, B; Junik, R; Kamińska, A; Włodarczyk, Z	1
Jiang, M; Li, F; Li, K; Luo, L; Meng, Q; Sun, C; Wang, C	1
Akbas, H; Akman, S; Comak, E; Dinckan, A; Dogan, CS; Koyun, M; Uslu Gokceoglu, A	1
Gipson, DS; Sethna, CB	1
Kirby, B; Ryan, C	1
Assenat, E; Bismuth, M; Carenco, C; Chanques, G; Danan, G; Duny, Y; Faure, S; Herrero, A; Jaber, S; Larrey, D; Navarro, F; Pageaux, GP; Ursic-Bedoya, J	1
Coss, E; Dierkhising, R; Fan, C; Fussner, LA; Heimbach, JK; Leise, MD; Watt, KD	1
Díez-Fuentes, ML; Fumero, C; Luis Lima, S; Porrini, E; Rodríguez-Rodríguez, AE; Salido, E; Torres, A; Triñanes, J; Vega-Prieto, MJ; Velázquez-García, S	1
Gao, M; Liu, D; Qu, S; Song, K; Yan, L	1
Gibson, R; Lees, CW; Lynch, RW; Pal, S; Soane, T	1
Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M	1
Del Giglio, M; Di Francesco, V; Girolomoni, G; Gisondi, P; Zamboni, M	1
Heinen, A; Hollmann, MW; Huhn, R; Preckel, B; Schlack, W; Weber, NC	1
Li, HT; Qiu, MC; Wang, ST	1
Feldman, SR; Rajpara, AN	1
Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K	1
Oh-i, T; Okuda, T	1
Evans, S; Goldsmith, D; Gordon, I; Maclean, D; Michael, R; Taylor, J; Wells, H	1
Lima, AS; Rego, LO; T D Correia, MI	1
Clerbaux, G; Goffin, E; Pirson, Y	1
Chan, MC; Gao, SZ; Hunt, SA; Robbins, RC; Shiba, N; Valantine, HA	1
el-Agroudy, AE; Gheith, OE; Ghoneim, MA; Shehab el-Dein, AB; Wafa, EW	1
Gunson, B; Johnson, J; Neuberger, J; Richards, J	1
Broelsch, CE; Hoyer, PF; Kranz, B; Malagò, M; Nadalin, S; Paul, A; Schaefer, A; Vester, U; Wingen, AM	1
Bora, S; Gülay, H; Kasap, B; Kavukçu, S; Soylu, A; Türkmen, M	1
Davies, K; Holt, S; Tomlinson, L; Wright, DA	1
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS	1
Emre, S; Facklam, D; Hasse, J; Miller, C; Mor, E; Schwartz, M; Sheiner, P	1
Demacker, PN; Hilbrands, LB; Hoitsma, AJ; Koene, RA; Stalenhoef, AF	1
Papadavid, E; Ryan, TJ; Yell, J	1
Bechstein, WO; Guckelberger, O; Jonas, S; Knoop, M; Kratschmer, B; Langrehr, JM; Lemmens, HP; Luesebrink, R; Neuhaus, P; Neuhaus, R	1
Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R	1
Anjum, MR; Bowley, JN; Drafts, HH; Humphries, AL; Mulloy, LL; Wynn, JJ	1
Canzanello, VJ; Krom, RA; Porayko, MK; Schwartz, L; Taler, SJ; Textor, SC; Wiesner, RH	1
Abe, H; Hoshino, N; Kodama, M; Minouchi, T; Park, K; Shibata, N; Tomoyoshi, T; Yamaji, A	1
Everhart, JE; Hoofnagle, JH; Lake, JR; Lombardero, M; Wiesner, RH; Zetterman, RK	1
Hayakawa, T; Hoshino, N; Minouchi, T; Shibata, N; Uehara, M; Yamaji, A	1
Furlanut, M; Wu, G	1
Bonacker, U; Nägele, H; Petersen, B; Rödiger, W	1
Colman, E; Fossler, M	1
Alfonso, I; Armijo, JA; Boada, JN; García-Sáiz, M; López-Gil, A	1
Luke, DR	1
Ament, ME; Busuttil, RW; Fortunat, M; Gornbein, JA; McDiarmid, SV; Saikali, D; Vargas, JH	1

Reviews

4 review(s) available for cyclosporine and Obesity

Article	Year
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Treatment of FSGS in Children. Advances in chronic kidney disease, 2014, Volume: 21, Issue:2 Topics: Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Murine-Derived; Antihypertensive Agents; Child; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Immunosuppressive Agents; Mycophenolic Acid; Obesity; Rituximab; Tacrolimus; Treatment Outcome; Vitamin D Deficiency	2014
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatologic clinics, 2015, Volume: 33, Issue:1 Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab	2015
Post-liver transplant obesity and diabetes. Current opinion in clinical nutrition and metabolic care, 2003, Volume: 6, Issue:4 Topics: Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Liver Transplantation; Obesity; Risk Factors	2003

Trials

5 trial(s) available for cyclosporine and Obesity

Article	Year
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. The American journal of clinical nutrition, 2008, Volume: 88, Issue:5 Topics: Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Diet, Reducing; Female; Humans; Life Style; Male; Middle Aged; Obesity; Psoriasis; Severity of Illness Index; Treatment Outcome; Weight Loss	2008
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. Transplantation proceedings, 1995, Volume: 27, Issue:1 Topics: Adult; Body Mass Index; Cholesterol; Cyclosporine; Follow-Up Studies; Humans; Liver Transplantation; Obesity; Tacrolimus; Time Factors; Triglycerides; United States; Weight Gain	1995
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients. Journal of the American Society of Nephrology : JASN, 1995, Volume: 5, Issue:12 Topics: Adult; Apolipoproteins; Arteriosclerosis; Azathioprine; Cholesterol, HDL; Cyclosporine; Female; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Kidney Transplantation; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Postoperative Complications; Prednisone; Prospective Studies; Proteinuria; Risk; Risk Factors	1995
Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:4 Topics: Adult; Area Under Curve; Creatine; Cyclosporine; Female; Hematocrit; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Obesity; Regression Analysis; Tissue Donors	1998

Other Studies

44 other study(ies) available for cyclosporine and Obesity

Article	Year
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids	2020
Relation Between Wound Complication and Lymphocele After Kidney Transplantation: A Monocentric Study. Transplantation proceedings, 2020, Volume: 52, Issue:5 Topics: Adult; Aged; Cyclosporine; Delayed Graft Function; Diabetes Complications; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Obesity; Retrospective Studies; Risk Factors; Sirolimus; Surgical Wound Dehiscence; Tacrolimus	2020
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS drugs, 2021, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult	2021
Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats. BMC complementary medicine and therapies, 2021, Mar-22, Volume: 21, Issue:1 Topics: Abietanes; Animals; Apoptosis; Cyclosporine; DNA, Mitochondrial; Heart; Kidney; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Obesity; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction	2021
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017, Volume: 17, Issue:11 Topics: Animals; Calcineurin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Nerve Tissue Proteins; NFATC Transcription Factors; Obesity; Rats; Rats, Zucker; Tacrolimus; Thinness	2017
A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis. Molecular metabolism, 2019, Volume: 21 Topics: Animals; Calcineurin Inhibitors; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Diet, High-Fat; Down Syndrome; Fasting; Gene Expression; Gluconeogenesis; Glucose; HEK293 Cells; Hepatocytes; Homeostasis; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Obesity; Phosphorylation; Transfection; Trisomy	2019
Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice. Dermatologic therapy, 2019, Volume: 32, Issue:3 Topics: Adult; Age Factors; Aged; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors	2019
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients. Transplantation, 2019, Volume: 103, Issue:11 Topics: Adiponectin; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Complications; Dyslipidemias; End Stage Liver Disease; Female; Humans; Immunosuppression Therapy; Insulin Resistance; Liver Transplantation; Male; Metabolism, Inborn Errors; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Risk Assessment; Tacrolimus; Transplant Recipients; Treatment Outcome	2019
Factors associated with glucose metabolism disorders after kidney transplantation. Endokrynologia Polska, 2013, Volume: 64, Issue:1 Topics: Blood Glucose; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Female; Glucose Metabolism Disorders; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Logistic Models; Male; Middle Aged; Obesity; Overweight; Prediabetic State; Risk Factors; Tacrolimus	2013
Cyclosporin A attenuates weight gain and improves glucose tolerance in diet-induced obese mice. Molecular and cellular endocrinology, 2013, May-06, Volume: 370, Issue:1-2 Topics: Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Cell Differentiation; Cyclosporine; Diabetes Mellitus, Type 2; Eating; fas Receptor; Glucose; Glucose-6-Phosphatase; Immunosuppressive Agents; Inflammation; Insulin Resistance; Interleukin-12; Interleukin-1beta; Interleukin-2; JNK Mitogen-Activated Protein Kinases; Lipid Metabolism; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protein Serine-Threonine Kinases; Signal Transduction; Stearoyl-CoA Desaturase; Transcription Factors; Tumor Necrosis Factor-alpha; Weight Gain	2013
Hyperuricemia in pediatric renal transplant recipients. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2013, Volume: 11, Issue:6 Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Cystatin C; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Male; Obesity; Overweight; Prevalence; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation	2013
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:6 Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Neoplasms; Obesity; Risk Factors; Smoking; Tacrolimus; Transplant Recipients	2015
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:7 Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cyclosporine; Diabetes Complications; End Stage Liver Disease; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tacrolimus	2015
Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2015, Volume: 35, Issue:3 Topics: Animals; Apoptosis; Calcineurin Inhibitors; Carbohydrate Metabolism; Cell Division; Cyclosporine; Diabetes Mellitus, Experimental; Drug Substitution; Glucose; Glucose Tolerance Test; Homeostasis; Insulin Resistance; Insulin-Secreting Cells; Obesity; Proinsulin; Rats; Rats, Zucker; Tacrolimus	2015
Modulation of Cell-Mediated Immunity to Suppress High Fat Diet-Induced Obesity and Insulin Resistance. Pharmaceutical research, 2016, Volume: 33, Issue:2 Topics: Animals; Cyclosporine; Diet, High-Fat; Fingolimod Hydrochloride; Gene Expression Regulation; Immunity, Cellular; Immunosuppressive Agents; Insulin Resistance; Mice, Inbred C57BL; Obesity; Weight Gain	2016
Bilateral lower limb weakness in acute severe ulcerative colitis. Lancet (London, England), 2016, Jul-02, Volume: 388, Issue:10039 Topics: Colitis, Ulcerative; Cyclosporine; Epidural Space; Glucocorticoids; Humans; Immunosuppressive Agents; Lipomatosis; Lower Extremity; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Obesity; Prednisolone; Spinal Cord Compression; Thoracic Vertebrae	2016
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries. International journal of dermatology, 2017, Volume: 56, Issue:4 Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index	2017
Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:10 Topics: Animals; Blood Glucose; Cyclosporine; Hemodynamics; Ischemic Postconditioning; Male; Metabolome; Methyl Ethers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Obesity; Prediabetic State; Rats; Rats, Zucker; Sevoflurane	2010
Gynecomastia, obesity and underdeveloped testis and penis: suspected hypophysitis successfully cured with low dose of cyclosporine A. Chinese medical journal, 2009, Nov-20, Volume: 122, Issue:22 Topics: Adult; Cyclosporine; Estrogens; Gynecomastia; Humans; Male; Obesity; Penis; Pituitary Diseases; Testis; Testosterone	2009
Adherence to treatment: still the forgotten variable. Archives of dermatology, 2010, Volume: 146, Issue:10 Topics: Cyclosporine; Dermatologic Agents; Humans; Medication Adherence; Obesity; Psoriasis	2010
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. Clinical pharmacokinetics, 2011, Dec-01, Volume: 50, Issue:12 Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Computer Simulation; Cyclosporine; Female; Gastrointestinal Tract; Humans; Kidney; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Obesity, Morbid; Pharmacokinetics; Phenytoin; Regional Blood Flow; Theophylline; Young Adult	2011
Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-density [correction for destiny] lipoprotein. European journal of clinical pharmacology, 2002, Volume: 58, Issue:4 Topics: Administration, Oral; Anticholesteremic Agents; Cyclosporine; Dermatologic Agents; Drug Synergism; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hyperlipoproteinemia Type II; Immunosuppressive Agents; Indoles; Lipoproteins, LDL; Middle Aged; Obesity; Psoriasis	2002
Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:2 Topics: Administration, Oral; Anti-Obesity Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Lactones; Male; Middle Aged; Obesity; Orlistat	2003
Interaction between sibutramine and cyclosporine. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:7 Topics: Adult; Appetite Depressants; Cyclobutanes; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Obesity	2003
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:10 Topics: Adult; Age Factors; Case-Control Studies; Coronary Artery Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Multivariate Analysis; Obesity; Postoperative Complications; Risk Factors; Sex Factors; Time Factors	2003
Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation, 2004, May-15, Volume: 77, Issue:9 Topics: Adult; Body Mass Index; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Obesity; Postoperative Complications; Risk Factors; Survival Analysis; Weight Gain	2004
Weight gain and obesity after liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:4 Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Obesity; Prospective Studies; Tacrolimus; Weight Gain	2005
Development of growth and body mass index after pediatric renal transplantation. Pediatric transplantation, 2005, Volume: 9, Issue:4 Topics: Antibodies, Monoclonal; Basiliximab; Body Height; Body Mass Index; Child; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Growth Disorders; Humans; Immunosuppressive Agents; Kidney Transplantation; Logistic Models; Male; Obesity; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Weight Gain	2005
Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients. Transplantation proceedings, 2006, Volume: 38, Issue:2 Topics: Adolescent; Adult; Body Mass Index; Child; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Obesity; Overweight; Retrospective Studies	2006
Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Antibodies, Monoclonal; Child, Preschool; Cyclosporine; Diagnostic Errors; Dwarfism; Granuloma; Hematuria; Humans; Immunosuppressive Agents; Infliximab; Male; Nephritis, Interstitial; Nephrosis, Lipoid; Nephrotic Syndrome; Obesity; Prednisolone; Proteinuria; Puberty, Delayed; Recurrence; Remission Induction; Tacrolimus; Tumor Necrosis Factor-alpha	2006
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:5 Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha	2008
Conjunctival oedema: a side-effect of cyclosporin and a consequence of obesity. The British journal of dermatology, 1996, Volume: 135, Issue:1 Topics: Adult; Conjunctival Diseases; Cyclosporine; Edema; Female; Humans; Immunosuppressive Agents; Obesity	1996
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? Transplantation proceedings, 1996, Volume: 28, Issue:6 Topics: Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Hypertriglyceridemia; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Obesity; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Tacrolimus	1996
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clinical transplantation, 1997, Volume: 11, Issue:1 Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Obesity; Prednisolone; Retrospective Studies; Risk Factors; Tacrolimus	1997
The impact of pre-transplant obesity on renal transplant outcomes. Clinical transplantation, 1997, Volume: 11, Issue:5 Pt 2 Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Obesity; Obesity, Morbid; Prednisone; Surgical Wound Infection; Survival Rate; Transplantation, Homologous; Treatment Outcome; Weight Gain	1997
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1997, Volume: 3, Issue:1 Topics: Adult; Benzothiadiazines; Blood Glucose; Blood Pressure; Body Weight; Cyclosporine; Diabetes Mellitus; Diuretics; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lipids; Liver Transplantation; Male; Middle Aged; Obesity; Prednisone; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Tacrolimus	1997
Weight change and obesity after liver transplantation: incidence and risk factors. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1998, Volume: 4, Issue:4 Topics: Adult; Aged; Body Mass Index; Cohort Studies; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Obesity; Prednisone; Risk Factors; United States; Weight Gain	1998
Effect of obesity on cyclosporine trough concentrations in psoriasis patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Aug-01, Volume: 55, Issue:15 Topics: Adult; Aged; Cyclosporine; Female; Fluorescence Polarization Immunoassay; Humans; Immunosuppressive Agents; Male; Middle Aged; Obesity; Psoriasis; Regression Analysis	1998
Prediction of blood cyclosporine concentrations in non-obese and obese hematologic patients with multidrug resistance using total, lean and different adipose factor dosing body weights. Haematologica, 1999, Volume: 84, Issue:5 Topics: Adult; Body Weight; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Male; Middle Aged; Obesity	1999
Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient. European journal of clinical pharmacology, 1999, Volume: 55, Issue:9 Topics: Anti-Obesity Agents; Area Under Curve; Cyclosporine; Drug Interactions; Enzyme Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Lactones; Lipase; Male; Obesity; Orlistat	1999
Reduction in blood cyclosporine concentrations by orlistat. The New England journal of medicine, 2000, Apr-13, Volume: 342, Issue:15 Topics: Absorption; Cyclosporine; Humans; Lactones; Obesity; Organ Transplantation; Orlistat	2000
Factors influencing cyclosporine blood concentration-dose ratio. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:2 Topics: Adult; Age Factors; Bilirubin; Cholesterol; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Obesity; Organ Transplantation	2002
Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model. Biopharmaceutics & drug disposition, 1992, Volume: 13, Issue:9 Topics: Animals; Body Weight; Cell Division; Cyclosporine; Female; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Obesity; Organ Size; Rats; Rats, Zucker; T-Lymphocytes	1992
Serum lipid abnormalities in pediatric liver transplant patients. Transplantation, 1992, Volume: 53, Issue:1 Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cyclosporine; Exercise; Female; Humans; Infant; Lipids; Liver; Liver Transplantation; Male; Obesity; Prednisone; Regression Analysis; Triglycerides	1992